Morgan Stanley
EXAS

Morgan Stanley’s Exact Sciences EXAS Stock Holding History

Morgan Stanley’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,250,329
Closed -$330M – 8356
2025
Q4 		$330M Buy
3,250,329
+1,880,828
+137% +$151M 0.02% 693
2025
Q3 		$74.9M Sell
1,369,501
-14,260
-1% -$712K ﹤0.01% 1666
2025
Q2 		$73.5M Sell
1,383,761
-391,564
-22% -$19.9M ﹤0.01% 1572
2025
Q1 		$76.9M Sell
1,775,325
-416,268
-19% -$21.1M 0.01% 1440
2024
Q4 		$123M Buy
2,191,593
+411,509
+23% +$25.6M 0.01% 1113
2024
Q3 		$121M Buy
1,780,084
+310,958
+21% +$17.5M 0.01% 1104
2024
Q2 		$62.1M Buy
1,469,126
+163,697
+13% +$9.01M ﹤0.01% 1549
2024
Q1 		$90.2M Sell
1,305,429
-1,422,105
-52% -$90M 0.01% 1270
2023
Q4 		$202M Buy
2,727,534
+1,333,454
+96% +$87.4M 0.01% 1145
2023
Q3 		$95.1M Sell
1,394,080
-254,311
-15% -$21.6M 0.01% 1094
2023
Q2 		$155M Sell
1,648,391
-350,463
-18% -$27.3M 0.02% 829
2023
Q1 		$136M Buy
1,998,854
+67,498
+3% +$4.34M 0.01% 887
2022
Q4 		$95.6M Buy
1,931,356
+269,799
+16% +$11M 0.01% 1060
2022
Q3 		$54M Buy
1,661,557
+359,554
+28% +$14.8M 0.01% 1264
2022
Q2 		$51.3M Buy
1,302,003
+30,009
+2% +$1.6M 0.01% 1343
2022
Q1 		$88.9M Buy
1,271,994
+395,098
+45% +$28.9M 0.01% 938
2021
Q4 		$68.2M Sell
876,896
-236,004
-21% -$20.8M 0.01% 1150
2021
Q3 		$106M Sell
1,112,900
-461,471
-29% -$48.7M 0.01% 812
2021
Q2 		$196M Buy
1,574,371
+98,577
+7% +$11.8M 0.03% 553
2021
Q1 		$194M Buy
1,475,794
+320,804
+28% +$43.9M 0.03% 493
2020
Q4 		$153M Buy
1,154,990
+250,805
+28% +$30.3M 0.02% 556
2020
Q3 		$92.2M Buy
904,185
+90,220
+11% +$7.79M 0.02% 620
2020
Q2 		$70.8M Sell
813,965
-65,525
-7% -$5.24M 0.02% 685
2020
Q1 		$51M Buy
879,490
+35,513
+4% +$2.88M 0.01% 733
2019
Q4 		$78.1M Sell
843,977
-118,417
-12% -$10.4M 0.02% 712
2019
Q3 		$87M Buy
962,394
+146,363
+18% +$16.7M 0.02% 607
2019
Q2 		$96.3M Buy
816,031
+82,382
+11% +$8.3M 0.03% 567
2019
Q1 		$63.5M Buy
733,649
+102,044
+16% +$8.69M 0.02% 717
2018
Q4 		$39.9M Sell
631,605
-172,698
-21% -$11.9M 0.01% 942
2018
Q3 		$63.5M Buy
804,303
+427,577
+113% +$27.9M 0.02% 809
2018
Q2 		$22.5M Sell
376,726
-426,941
-53% -$23M 0.01% 1525
2018
Q1 		$32.4M Sell
803,667
-939,103
-54% -$45.8M 0.01% 1238
2017
Q4 		$91.6M Buy
1,742,770
+329,245
+23% +$17.6M 0.03% 629
2017
Q3 		$66.6M Buy
1,413,525
+161,113
+13% +$6.49M 0.02% 751
2017
Q2 		$44.3M Buy
1,252,412
+855,876
+216% +$26.4M 0.01% 981
2017
Q1 		$9.37M Sell
396,536
-254,130
-39% -$5.04M ﹤0.01% 2261
2016
Q4 		$8.69M Buy
650,666
+212,801
+49% +$3.44M ﹤0.01% 2405
2016
Q3 		$8.13M Buy
437,865
+16,283
+4% +$287K ﹤0.01% 2194
2016
Q2 		$5.16M Sell
421,582
-97,116
-19% -$731K ﹤0.01% 2589
2016
Q1 		$3.5M Buy
518,698
+184,607
+55% +$1.18M ﹤0.01% 2850
2015
Q4 		$3.08M Sell
334,091
-12,608
-4% -$117K ﹤0.01% 3114
2015
Q3 		$6.24M Sell
346,699
-12,257
-3% -$282K ﹤0.01% 2447
2015
Q2 		$10.7M Sell
358,956
-3,736
-1% -$93.9K ﹤0.01% 2049
2015
Q1 		$7.99M Buy
362,692
+88,133
+32% +$2.24M ﹤0.01% 2298
2014
Q4 		$7.53M Sell
274,559
-54,893
-17% -$1.34M ﹤0.01% 2327
2014
Q3 		$6.38M Buy
329,452
+152,269
+86% +$2.79M ﹤0.01% 2425
2014
Q2 		$3.02M Sell
177,183
-25,797
-13% -$355K ﹤0.01% 3142
2014
Q1 		$2.88M Buy
202,980
+104,277
+106% +$1.41M ﹤0.01% 3115
2013
Q4 		$1.16M Buy
98,703
+11,825
+14% +$136K ﹤0.01% 3816
2013
Q3 		$1.02M Buy
86,878
+545
+0.6% +$6.99K ﹤0.01% 3765
2013
Q2 		$1.2M Buy
+86,333
New +$938K ﹤0.01% 3571

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Morgan Stanley's EXAS Position: Q1 2026 in Review

Morgan Stanley sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,250,329 shares — an estimated $330M sold.

Morgan Stanley first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $330M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Morgan Stanley reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Morgan Stanley sold 3,250,329 Exact Sciences shares in Q1 2026, an estimated $330M.
  • Morgan Stanley first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Morgan Stanley's Exact Sciences position peaked at $330M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.